50
Participants
Start Date
March 17, 2024
Primary Completion Date
September 30, 2024
Study Completion Date
October 31, 2024
Morphine
The patients will receive 0.1 mg morphine with 15 mg heavy bupivacaine intrathecally
Placebo
The patients will receive 15 mg heavy bupivacaine with 0.1 ml saline intrathecally
RECRUITING
Kasr Alaini hospital, Cairo
Cairo University
OTHER